The burden of hyperkalaemia in chronic kidney disease: a systematic literature review

Jürgen Floege1, Andrew H Frankel2, Kevin F Erickson3

  • 1Division of Nephrology and Dept of Cardiology, RWTH Aachen University, Aachen, Germany.

PubMed

Insights

Hyperkalaemia in chronic kidney disease (CKD) patients is common and linked to adverse outcomes. Managing this condition, especially with renin-angiotensin-aldosterone system inhibitors (RAASi), requires careful consideration due to significant health and economic impacts.

Area of Science:

  • Nephrology
  • Pharmacology
  • Public Health

Background:

  • Hyperkalaemia is a common complication in chronic kidney disease (CKD) patients.
  • Inconsistent definitions obscure the true global epidemiology and burden of hyperkalaemia.
  • Understanding hyperkalaemia is crucial due to adverse effects and drug interactions, particularly with renin-angiotensin-aldosterone system inhibitors (RAASi).

Purpose of the Study:

  • To systematically review and summarize evidence on hyperkalaemia risk factors in adult CKD patients.
  • To describe characteristics associated with hyperkalaemia, including the impact of sub-optimal RAASi use.
  • To explore the clinical and economic outcomes of hyperkalaemia in CKD.

Main Methods:

  • Systematic literature review of Medline and Embase databases (2000-2024) with hand searching.
  • Screening by two independent reviewers; data extraction and quality assessment by separate reviewers.
  • Descriptive summarization of identified studies.

Main Results:

  • 138 studies (145 publications) met eligibility criteria.
  • Hyperkalaemia prevalence varies with definitions but is significantly increased in CKD patients, irrespective of RAASi treatment.
  • Hyperkalaemia is associated with adverse outcomes, increased healthcare resource utilization, and negative economic impacts, particularly with sub-optimal RAASi dosing in CKD patients with or without heart failure.

Conclusions:

  • This review provides a comprehensive overview of hyperkalaemia in CKD, focusing on clinical and economic outcomes.
  • The interplay between hyperkalaemia risks and sub-optimal RAASi dosing necessitates further research.
  • Clinicians must exercise caution when managing hyperkalaemia in CKD patients.
Abstract

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
424
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
309
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
118
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.0K
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
1.9K